Features of Lung Cancer Treatment–Related AML
Therapy-related AML after lung cancer is rare, but is associated with poor prognosis.
Hematologic Cancers
Simple Flow-Based Prognostic Score Developed for Patients With MDS
Although other flow cytometry–based prognostic scores have been proposed in the setting of MDS, their complexity has limited their clinical use.
HCT Deemed More Favorable for MDS That Is High Risk
HCT resulted in a lower risk of death among patients with high risk disease or if performed shortly after diagnosis, according to an observational study.
Does Type of Radiation Therapy in Hodgkin Lymphoma Treatment Affect Lung Toxicity?
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Myelodysplastic Syndromes: Gene Expression Signatures May Predict Response to Azacitidine
Among some patients with myelodysplastic syndrome, gene expression signatures appear to be predictive of response and primary resistance to azacitidine.
Current Treatment Options for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
Risk Factors for Early Relapse of DLBCL After CAR-T Therapy
Nearly half of all relapses occurred within the first month of CAR-T infusion.
Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Loncastuximab Tesirine Gets Priority Review for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Loncastuximab tesirine is an antibody drug conjugate composed of a humanized monoclonal antibody directed against human CD19 and conjugated through a linker to a pyrrolobenzodiazepine dimer cytotoxin.
Adherence to Allogeneic Stem Cell Transplantation to Improve Survival in Myelodysplastic Syndromes
With the exception of alloSCT and iron chelation therapy, many guideline treatments may not improve survival among patients with myelodysplastic syndrome.
-
Loading...
-
Loading...
Next post in Multiple Myeloma
